期刊文献+

^(99)Tc^m-Cl_2MDP-明胶微粒的制备及其肝脾靶向性研究 被引量:2

Preparation of 99Tcm-Cl_2MDP-loaded gelatin particles and its liver and spleen targeting study
在线阅读 下载PDF
导出
摘要 目的研究粒径300~500nm、表面带正电荷的明胶微粒对二氯亚甲基二膦酸盐(Cl2MDP)的包封技术,并观察明胶微粒和载药明胶微粒在SD大鼠体内的分布。方法通过静电吸附将Cl2MDP连接到明胶微粒表面完成药物包封。用99Tcm标记,进行SD大鼠生物学分布实验和显像,观察明胶微粒和Cl2MDP明胶微粒的组织靶向特性。结果通过静电吸附法可将Cl2MDP连接到明胶微粒表面,其药物包封效率约为20%,最大载药量达6mgmg明胶微粒;生物学分布实验和放射性核素显像示其具有较好的肝脾靶向性,可将Cl2MDP定向输送到巨噬细胞,肝脾的摄取超过注射量的60%。结论该明胶微粒具有良好的肝脾网状内皮系统靶向性,是较理想的以肝脾巨噬细胞为作用靶点的药物靶向输送载体;明胶微粒通过静电吸附的方法包封Cl2MDP简便可行,具有较高的药物包封效率和载药量。 Objective To investigate the coating technology of 300~500 nm, positive charged gelatin particles, encapsulate with dichloromethylene diphosphonate (Cl_2MDP), and to study the biodistribution of gelatin particles and drug-loaded gelatin particles. Methods Cl_2MDP was encapsulated on the surface of gelatin particles by static adsorption, and then labeled with 99Tcm. Biodistribution and radionuclide imaging were used to observe their tissue targeting characteristics in rats. Results Cl_2MDP can be facilely encapsulated to surface of gelatin particles with coating efficiency reached about 20%, and the maximal Cl_2MDP drug-loading amount was 6 mg/mg gelatin particles. Biodistribution and gamma imaging showed that more than 60% of injected particles were concentrated in macrophages of the liver and spleen. Conclusions The method of encapsulating Cl_2MDP is simple, convenient and highly efficient. Gelatin particles with diameter 300~500 nm and positive charged on their surface, have favorable targeting reticuloendothelial system characteristics in liver and spleen, and is a perfect carrier for those drug acting on macrophages.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2005年第3期181-183,i004,共4页 Chinese Journal of Nuclear Medicine
  • 相关文献

参考文献6

  • 1Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanospheres. Science, 1994, 263: 1600-1603.
  • 2谭忠华.载药纳米微粒靶向输送和控释系统的研究进展[J].国外医学(放射医学核医学分册),2003,27(5):204-207. 被引量:5
  • 3Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev, 2001, 53: 283-318.
  • 4Qi P, Muddukrishna SN, Torok-Both R, et al. Direct ^99Tcm labeling of antibodies by sodium dithionite reduction, and role of ascorbate as a stabilizer in cysteine challenge. Nucl Med Biol, 1996, 23: 827-835.
  • 5Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages:mechanism of action, preparation of liposomes and applications. J Immunol Meth, 1994, 174: 83-93.
  • 6Plosker GL, Goa KL. Clodronate: a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs, 1994, 47:945-982.

共引文献4

同被引文献21

  • 1Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med, 2002, 346 : 995 - 1008
  • 2Gernsheimer T, Stratton J, Ballem PJ, et al. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N Engl J Med, 1989; 320:974 -980
  • 3Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood, 1989, 74:2309 -2317
  • 4Anonymous. Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel. Ann Intern Med, 1997; 126:319 -326
  • 5George JN, Davidoff F. Idiopathic thrombocytopenic purpura. Lessons from a guideline. Ann Intern Med, 1997; 126:317 -318
  • 6Alves-Rosa F, Stanganelli C, Cabrera J, et al. Treatment with liposome- encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood, 2000 ; 96 : 2834 - 2840
  • 7Alves-Rosa F, Stanganelli C, Cabrera J, et al. Rapid recovery of platelet count following administration of liposome-encapsulatod clodronate in a mouse model of immune thrombocytopenia. Br J Haematol, 2002; 116:357 -366
  • 8Alan YS, Byrness JJ, Harrington WJ, et al. The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. N Engl J Med, 1978; 298:1101 -1107
  • 9Van Rooijen N. The liposome mediated macrophage " suicide"technique. J Immunol Meth, 1989; 124:1 -6
  • 10Oyaizu N, Yasumizu R, Miyama-Inaba M, et al. (NZW × BXSB ) F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J Exp Med, 1988; 167:2017 -2022

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部